Physician

Dan Krakora

According to 2025 Medicare claims, Dan Krakora (NPI: 1548622863) practices dermatology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from St. Croix, WI. This provider's primary affiliated billing organization is GROUP HEALTH PLAN INC (NPI: 1427420181; TIN: 410797853) and primary practice location at 54016-7848. Krakora is affiliated with the Park Nicollet Health Services ACO LLC d/b/a HealthPartners ACO (ACO ID: D0207), participating under the REACH model.

Krakora's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 360 traditional Medicare patients, billed 1,484 HCPCS/CPT codes, and received $68,427 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 630 prescription claims across 226 beneficiaries totaling $513,485 in drug costs, led by Dupixent Syringe (Dupilumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,172 to $513,485. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$47K$95K2020 Medicare payment: $13,841 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,656 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $94,680 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $84,733 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $68,427 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202095238$13,841
20212741,513$68,656
20223442,184$94,680
20234101,723$84,733
20243601,484$68,427

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$257K$513K2017 Drug cost: $3,172 (USD; Tot_Drug_Cst)2018 Drug cost: $6,760 (USD; Tot_Drug_Cst)2019 Drug cost: $135,399 (USD; Tot_Drug_Cst)2020 Drug cost: $125,635 (USD; Tot_Drug_Cst)2021 Drug cost: $112,199 (USD; Tot_Drug_Cst)2022 Drug cost: $367,947 (USD; Tot_Drug_Cst)2023 Drug cost: $497,289 (USD; Tot_Drug_Cst)2024 Drug cost: $513,485 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20174172$3,172
201853116$6,760
201959176$135,399
202081195$125,635
2021204500$112,199
2022206554$367,947
2023227584$497,289
2024226630$513,485

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9696$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more215264$56
11102Biopsy of related skin growth, first growth6369$55
17000Destruction of precancer skin growth, 1 growth138165$31
17003Destruction of precancer skin growth, 2-14 growths91393$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab17476$75,048
Clobetasol PropionateClobetasol Propionate731,927$2,651
Azelaic AcidAzelaic Acid19565$2,124
CalcipotrieneCalcipotriene12290$1,357
KetoconazoleKetoconazole541,823$983

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Dan Krakora?

Tedicare shows public-source Medicare data for Dan Krakora (NPI 1548622863), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dan Krakora have ACO affiliation data?

Dan Krakora is shown with ACO affiliation data for Park Nicollet Health Services ACO LLC d/b/a HealthPartners ACO (REACH, ACO ID D0207).

What billing organization is linked to Dan Krakora?

Dan Krakora is linked to GROUP HEALTH PLAN INC (billing NPI 1427420181) in the available physician profile data.

Does Dan Krakora have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.